chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I developed pain and tingling (pins and needles sensation) in my hands and feet the day after receiving the vaccine.  The pain initially interfered with my ability to type and use my hands for normal activity. The pain and tingling has subsided in severity, but continues to occur sporadically.  Now, approximately 4 weeks later, I still experience occasional tingling/pin and needles sensation in my arms, hands, legs and feet. I have spoken with my primary care doctor and decided to delay and possibly skip the second dose.  My PCP has also referred me to a neurologist.
Started to have chest palpitations, couldn't lift left arm, left chest pain, weight loss, anxiety, tremors, blood pressure fluctuations, high pulse.  Hyperthyroidism started.  Saw numberous doctors, had emergency room visit and just had a first visit with an endocrinologist on Wednesday, August 11.  Prescribed Methimazole.  And am taking atenolol.  Prior to May, I was not taking any medication and am a completely healthy person.
My heart felt swollen and constriction in my chest. Felt like I was about to have a heart attack. Lasted for about 6 hours.  Never felt anything like this in my life.
Patient inadvertently received vaccine after published expiration date. Moderna Company analyzed lot 007B21A and advised vaccine maintained activity needed to protect against covid 19 on date vaccine was administered. Also patient did not call in to report adverse event. This is administrative error without adverse event.
This spontaneous report as received from a county health nurse/registered nurse refers to 3 patients of unknown age and gender, who on unspecified date were vaccinated, by the physician with improperly stored M-M-R II (dates, route of administration, dose, frequency, lot and expiry date were not reported). No adverse effect was reported at this time. This is one of several reports received from the same reporter. Additional information is not expected because there is no consent to contact the reporter.
Site: Swelling at Injection Site-Mild, Systemic: Patient fell off and fainted for 1 minute-Mild, Additional Details: EMT came and checked on her vitals. Everything was normal. Pt left and drove home safety
16 year old had completed a full series of the GARDASIL 9 and then was given a 4th or additional dose; No additional AE details; This spontaneous report has been received from a pharmacist and refers to a 16-year-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not provided.  On an unknown date, the patient was vaccinated with the 1st dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, lot number, expiration date, and route of administration were not provided). The patient completed the full series of the vaccine and then was given a 4th dose. No additional adverse event reported (extra dose administered).
Employee became SOB and warm soon after vaccination.  Helped to floor; 02 at 2L per N/C started.  HR elevated; having difficulty breathing so EpiPen 1:1000 given IM in left thigh.  Adult code blue called.  Code team arrived within 30 seconds to one minute and employee transported to ER via gurney.    Per ER Notes: DEXAmethasone (DECADRON) 10 mg/mL injection for oral use 10 mg (10 mg Oral Given 12/28/20 1301)  Patient is in no acute distress, states that she feels well.  History and physical exam as above.  Patient states that her symptoms have resolved as of arriving in the emergency department.  We will assume that this was an anaphylactic reaction, she was not given time to develop all signs and symptoms of anaphylaxis, however she was given an EpiPen and her dyspnea rapidly improved and therefore we will treat her as if she experience anaphylaxis.  She will be kept in the emergency department for 6 hours for observation, she was given 10 mg of p.o. Decadron.  At the time of my shift change she continued to be hemodynamically stable, awake, and talkative. She still required ~3 hours of observation at that time. I saw this patient with attending physician, please see her note for ultimate disposition or further developments.
Information has been received from a registered nurse concerning an 11 year old male patient with severe poison ivy was exposed to chickenpox, natural varicella which his sister had contracted, approximately two days before he was vaccinated on 6/24/2005 with a dose of varicella virus vaccine live, as a post exposure prophylaxis measure. Concomitant therapy included steroids liquid prednisone (manufacturer unknown). It was noted about 10 days later, on approximately 4/4/2005 he experienced a mild varicella rash. It was described as a raised non vesicular rash on his neck, face, arms, lower abdomen and legs. he had very few spots, under 50. There was no product quality complaint reported. No other information was available regarding the patients outcome. The patient sought unspecified medical attention. Follow up information was received from the registered nurse which reported that the patient recovered. No additional information is expected.
Allergies: Prevnar 13 (pneumococcal13-val conj vacci) - Rash; Allergies: Prevnar 13 (pneumococcal13-val conj vacci) - Rash; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 69 year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) (Batch/Lot number: unknown) as dose number unknown, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALLERGY TO VACCINE (non-serious), DERMATITIS ALLERGIC (non-serious), outcome "unknown" and all described as "Allergies: Prevnar 13 (pneumococcal13-val conj vacci) - Rash".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fatigue, body aches, and chills for about 12-18 hours (6 PM Monday evening - 12 PM Tuesday).
At 5:38;client had an episode of syncope, upon arrival she was pale,oriented. snacks and water was given,client claim she has not eaten since 10am this morning. Client was hypotension when vital sign was done. but after eaten color she started feeling better,vs stable. At 5:55pm. client was stable, was wheel out via wheelchair with ems to her car.
This spontaneous report was received from a female patient of unknown age regarding herself. The patient's pertinent medical history and concurrent conditions were not reported. On an unknown date in 2008 the patient was vaccinated with dose 1 of GARDASIL (# lot/batch, dose, route unknown) and never received the rest of the series. Product quality complaint was not filed. Additional information is not expected as no contact details for further follow up were provided.
A report has been received from a Pharmacist concerning a 44 year old, female subject, who had been receiving FLUMIST. FLUMIST started on an unknown date. The reporter reported that on 11-Nov-2013 multiple patients received only a half dose of FLUMIST in one nostril which started on 11-Nov-2013. The outcome of the event of administration of only a half dose of FLUMIST in one nostril is unknown. The report was considered to be non-serious. Corrected report 10-Dec-2013: The key ingredient of the suspect product was corrected from FLUMIST to Q/LAIV.
itchy,throat problem. Pt states the right arm at the shot is itchy up to the right side of the head. Pt report feeling like she was having difficulty swallowing. Pt states if feels much better.Pt still feels like something is in the throat.
it's more irritating at night, mind bogling; numbness in tingling in both legs from knees; numbness in tingling in both legs from knees; This case was reported by a consumer via call center representative and described the occurrence of irritability in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On 13th April 2022, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 13th April 2022, less than a day after receiving Shingrix, the patient experienced irritability, numbness and tingling. The patient was treated with ibuprofen (Advil). On an unknown date, the outcome of the irritability, numbness and tingling were not recovered/not resolved.   It was unknown if the reporter considered the irritability, numbness and tingling to be related to Shingrix.     Additional Information: GSK Receipt Date: 20-Sep-2022 Reporter's comment: The patient stated that at night from 11 pm to 5 am, she felt like her throughout whole body was being electrocuted.  The patient had almost went to hospital.  The patient almost went to Emergency Room both knees down constant feeling of prickly numbness, down to toes and bottom of feet. She still had tingling in both legs from knees down. The patient felt mind boggling.  It was more irritating at night.  She spoke with her Healthcare professional and had began taking Advil at night.  The patient was referred to Healthcare professional, medical information phone number was provided. The patient had gone through every February for physical.  The permission for consent to follow-up was denied.
pt seen by MD 27JAN98 for swollen glands beneath both ears;MD exam states on PE there is bilat swollen parotid glands approx 2-2 1/2in diameter, not tender to touch;ear exam neg;T97.6 ear;dx poss mumps;5FEB98 mumps IgM <1:10;mumps IgG <1:5;
Information has been received from a pharmacist referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medication were not reported. On an unknown date, the patient vaccinated with ZOSTAVAX 19400 PFU (dose and strength unknown, lot number L046295, expiration date 17-FEB-2017) that had bubbles, subcutaneously. Product quality issue was involved (00168231). No symptoms were reported. Additional information is not expected as the pharmacist refused to be contacted.
A few days after immunization, mom noticed a small red bump and some swelling at the vaccine site on her left thigh. This has become larger, more "knot" like, and continued to have redness. She seems irritable and does not like anyone to touch it. Noted 2-3 cm of erythema and swelling of the left thigh that has continued to worsen since vaccines (including MMR and varicella) one week and a half ago. Presentation consistent w/ delayed local reaction to vaccines, likely due to MMR and/or varicella vaccines given time frame of delayed reaction within two weeks. No respiratory symptoms and today afebrile. Advised cold compressed and tylenol/ibuprofen as needed for pain control.
Fever and chills  started at 4am on Saturday, February 12th. This led to me walking in the middle of the night and getting up and passing out on the floor. I woke back up but was not 100% for 2 more days.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 31Jan2023 as dose 6 (booster), single (Batch/Lot number: unknown) at the age of 43 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown) and as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 treated with Paxlovid started on 20May2023 and stopped on 24May2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Lower back inflammation  Began at 8:30am, 4/5/2021, hard to walk took tylenol every 4 hours, ice and heat, rest, stretching.
Immunization was given out of a vial that was opened the day before.  Dose given on 8/17/23.  Vial opened on 8/16/2023
Pt received both doses of Pfizer on 3/18/21 and 4/8/21. Adverse event is a breakthrough COVID-19 case
Asthma and allergy flare-up. Used emergency inhaler and took Claritin Reditab and symptoms cleared within half an hour.
Patient presented to the community vaccine clinic for a Janssen Vaccine for COVID-19 at 2:18 pm.  Prepped patient's arm with an alcohol pad and gave the injection in the right arm deltoid muscle. Due to patient' previous response to the Pfizer vaccine, staff was monitoring patient closely for signs/symptoms of a reaction. Within 10 minutes of receiving the vaccine patient complained of itching all over. AT ~2:32pm HR:100 and oxygen saturations:99%, % were obtained. Writer called the emergency response team and then gave an injection of an epi-pen 0.3 mg dose at 2:32 pm. At ~2:38 pm, the patient was transported to the emergency department of this facility, for further monitoring and treatment.
MD ordered LPN to give Hep A and PREVNAR. PENTACEL given by LPN instead of PREVNAR. Patient recalled same day / stable / no adverse effects noted / pt given needed PREVNAR / discussed incident w/ mom. No fever / no localized reaction.
Vomiting and diarrhea same day as vaccine.  Hives day after vaccine lasting for three days to date.
Information has been received from a licensed practical nurse concerning a 11 week male infant who on 19-JUN-2008 was vaccinated orally with a first dose of an individual pouch single-dose tube of ROTATEQ (Oka/Merck) (lot # 660379/0144X). It was reported that the infant spit up the first part of the dose, then when more was given there was "projectile vomiting." When the remainder of the dose was provided the infant spit it out. Unspecified medical attention was sought. There were no other problems reported. At the time of report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Fever 101F, aching arms and legs, cramping, chills, traphorisis. Abdomen pain, mild nausea, headache. Treated with Ibuprofen, increase fluids
No additional AE; administration of improperly stored VARlVAX; This spontaneous report was received from a caller (unspecified) informing agent of the administration and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 15-SEP-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # T002842, expiration date 23-JAN-2022 (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of -8 to -14 degrees Celsius from 05-SEP-2020 to 15-SEP-2020. Data logger was involved. There were no previous excursions reported.
This case was reported by a healthcare professional and described the occurrence of Guillain-Barre Syndrome in a 36-year-old male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). On 25 October 2011 the subject received a dose of FLULAVAL (.5 cc, unknown route, left arm). The vaccine was administered at an onsite clinic for employees. On 26 October 2011, 1 day after vaccination with FLULAVAL, the subject experienced numbness of left side of body and weakness on left side of body. The subject reportedly went to work that day. On 27 October 2011, the subject woke up and could barely move his left hand, his left side was still numb and he also experienced leg weakness in both legs. His right hand and right side of body were "almost paralyzed". His right hand was nonfunctional and remained that way at the time of reporting. The subject was hospitalised and was diagnosed with Guillain Barre Syndrome. The subject was hospitalised for 22 days and the healthcare professional considered the events were disabling and clinically significant (or requiring intervention. The subject was treated with normal immunoglobulin for five and a half days. He was discharged from hospital on 17 November 2011. At the time of reporting, the subject was still receiving occupational therapy, both of his legs were still weak and he was using a walker for long distance or stairs. The healthcare professional also reported that his right hand was "worthless" and his right arm was "half as good as his left". His left arm was noted to be fine from his elbow down to his hand. The subject was unable to raise his arms above his shoulders. It was noted that the subject had no breathing problems in the hospital. At the time of reporting the events of Guillain Barre Syndrome, leg weakness and paralysis were unresolved. The outcome of the other events was not specified.
An expired vaccine dose that had been left in the fridge the previous night was erroneously administered to the patient the following morning.
Pt was given 5 vaccines on 8/16/13 and found out she was pregnant on 8/21/13. Pt is in her 1st trimester.
49 y.o male with a history of DMII, HTN, DVT, and obesity who was admitted for COVID-19 illness 3 months ago who developed fatigue, shortness of breath, malaise, and abdominal pain after receiving the Moderna COVID-19 vaccine. The symptoms persisted and two days after receiving the vaccine he developed chest tightness and left arm pain which prompted him to be evaluated in the emergency department.
I had no symptoms at the tome of the vaccine but about two weeks later, I began experiencing hives, urticaria, and redness at night for several days. I?ve never experienced hives before but they came every day for about a week. After my second dose, I haven?t experienced any symptoms or hives.
Information has been received from a registered nurse concerning an 8 year old male who on 03-Nov-2000 was vaccinated with the first dose of VARIVAX (Merck), and on 05-Feb-2007 was vaccinated with the second dose of 0.5ml of VARIVAX (Merck) (lot# 653517/1300F). The registered nurse reported that on 08-Apr-2008 the patient experienced a chickenpox rash on his chest, abdominal area and back. It was noted that the patient was afebrile and had fewer than 50 lesions. The patient was prescribed ZYRTEC to help with the itching. The patient had not recovered from the chickenpox rash on his chest, abdominal area and back. There was no product quality complaint. No further information is available.
Swelled arm and sore for about 5 days. Shots given in same arm. Urinated in bed. Collapsed in hallway that nite.
mom stated child recv vax 9JAN97 & has black bruise & a knot on leg p/vax;pt cries when touch knot;mom told it should go away to wait 60 days;pt had fever 2wk p/vax;mom will call a lawyer if knot doesn't go away tomorrow;
Drug Allergies: Prevnar 13; This is a spontaneous report from contactable physicians received from a Pfizer-sponsored program. A 70-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient's drug allergies included pneumococcal 13-val conj vac (dipht crm197 protein). The outcome of the event was unknown.
I got symptoms of headache, sinus drainage, cough, and chest congestion for 3 days and went away. My wife had it at the same time. I could not get a COVID test due to supply issues in my area. I did call my doctor and she stated those are the symptoms but she could not test due to having no tests available.
COVID 19 treatment; COVID 19 treatment; 27 weeks pregnant; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 35-year-old female patient (pregnant) received BNT162b2 (BNT162B2 NOS), on 17Mar2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 35 years for COVID-19 immunisation. The patient's relevant medical history included: "Known allergies: Ni" (unspecified if ongoing). Date of last menstrual period: 18Sep2022. The patient was 27 weeks pregnant at the time of exposure to BNT162b2. The patient was 27 weeks pregnant at the event onset. The patient is expected to deliver a baby(s) on 11Jul2023. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 treatment"; MATERNAL EXPOSURE DURING PREGNANCY (non-serious), outcome "unknown", described as "27 weeks pregnant". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included Paxlovid from 03Apr2023 to 07Apr2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Redness, swelling, warmth at injection site.  The area of redness is 4" in diameter.
pt recv vax; had rash around mouth and nose Sat. am; had fever at noc; rash turned into blisters;
pt reported symptoms of swelling, redness, soreness, and nausea that began the day prior to receiving the vaccine.
Mild arm soreness at injection site Began approximately 3 hours after administration and persisted for 24 hours. Patient (self) took 400 mg ibuprofen by mouth approximately 24 hours later (1:00pm 1/9/21), which relieved symptoms.
Information has been received from a medical assistant concerning a patient who was vaccinated with a dose of 0.5ml of PNEUMOVAX 23 (Lot# 665925/0932Z) (Exp 07/18/2011), IM right arm. The medical assistant stated that on unspecified date the patient developed a lump and a big red spot at the injection site that traveled down the whole right arm 24 hours post vaccination. At the time of the report the patient outcome was unknown, there were no diagnostics studies performed. The patient sought unspecified medical attention. A lot check has been initiated. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. This is one of several reports from the same source. Additional information has been requested.
I did not have an adverse reaction to the vaccine. I was exposed to COVID-19 with my husband. Six days later, I tested positive for COVID-19 on 03/05/2023. I contacted my doctor and was given the prescription Molnupiravir. I tolerated the medication without any complications. As of today, I still have a cough and a postnasal drip. I continue to test for concern of rebound.
Patient was injected higher than recommended dose for 5-11 yr old children. Next day she had 120+ fever, nausea, vomiting, headache, stomach pain, pain in other parts of body, not eating and some of these symptoms still exists after 72 hrs. She is still not eating well and feels nausea and has weakness. I was called by store today and was informed about the error in injection. They informed they injected the vaccine without dilution !!